JeffreyRobertAndolinaMD

Pediatric Hematology & Oncology • Rochester, NY

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Associate Professor, Pediatrics, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Andolina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Andolina's full profile

Already have an account?

Office
601 Elmwood Ave
# 777
Rochester, NY 14642
Phone+1 773-308-4368

Summary

Dr. Jeffrey Andolina is a pediatric hematologist/oncologist in Rochester, NY and is affiliated with Strong Memorial Hospital of the University of Rochester. He received his medical degree from University of Virginia School of Medicine and has been in practice 13 years. He specializes in pediatric leukemia, lymphoma, neuroblastoma, and pediatric bone marrow transplantation.

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2007 - 2010
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2004 - 2007
University of Virginia School of MedicineClass of 2004

Certifications & Licensure

NY State Medical License 2010 - 2025
IL State Medical License 2004 - 2011
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
URMC Related Haplo-identical Donor BMT Start of enrollment: 2015 Oct 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series.
Acacia Bowden, Jeanette Zambito, Jinia El-Feghaly, Jeffrey R Andolina
Pediatric Hematology and Oncology. 2024-09-01
Association of crystalloid fluid infusion with intravascular hemolysis and organ dysfunction in hematopoietic stem cell transplant patients.
Melissa R Holloway, Thomas Fountaine, Kelly Henrichs, Tate Feeney, Jeffrey Andolina
Transfusion and Apheresis Science. 2023-06-01
2 citations
Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.
Rose Parisi, Roshal R Patel, Gavrielle Rood, Acacia Bowden, George Turco
Pediatric Blood & Cancer. 2023-03-01

Journal Articles

Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204
Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood

Abstracts/Posters

Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
Jeffrey R. Andolina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC CentersDecember 3rd, 2020
Breaking ThroughOctober 19th, 2023
New Leadership Roles Look to Capitalize on Hematology/Oncology MomentumOctober 19th, 2023